Zoetis (ZTS) Inventory Average (2013 - 2026)
Zoetis (ZTS) posted quarterly Inventory Average of $2.5 billion for Q1 2026, up 7.34% year-over-year from $2.3 billion in Q1 2025, and up 1.72% quarter-over-quarter from $2.5 billion in Q4 2025.
Zoetis (ZTS) Inventory Average (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Inventory Average for 14 consecutive years, with $2.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 7.34% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (up 7.34% YoY), while the FY2025 annual figure was $2.4 billion, down 2.05% from the prior year.
- Inventory Average advanced to $2.5 billion in Q1 2026 per ZTS's latest filing, from $2.5 billion in the prior quarter.
- Across five years, Inventory Average topped out at $2.7 billion in Q3 2023 and bottomed at $2.0 billion in Q1 2022.
- Historically, Inventory Average has averaged $2.4 billion across 5 years, with a median of $2.5 billion in 2025.
- Annual changes were most pronounced in 2023 — Inventory Average climbed 23.51% — and 2024, when it retreated 11.04%.
- Zoetis' Inventory Average stood at $2.3 billion in 2022, then climbed by 14.2% to $2.7 billion in 2023, then declined by 11.04% to $2.4 billion in 2024, then gained by 4.38% to $2.5 billion in 2025, then advanced by 1.72% to $2.5 billion in 2026.
- Business Quant data shows ZTS's Inventory Average at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56 Bn |
| Mar 31, 2026 | 2.51 Bn |
| Dec 31, 2025 | 2.46 Bn |
| Sep 30, 2025 | 2.45 Bn |
| Jun 30, 2025 | 2.40 Bn |
| Mar 31, 2025 | 2.34 Bn |
| Dec 31, 2024 | 2.36 Bn |
| Sep 30, 2024 | 2.43 Bn |
| Jun 30, 2024 | 2.55 Bn |
| Mar 31, 2024 | 2.61 Bn |
| Dec 31, 2023 | 2.65 Bn |
| Sep 30, 2023 | 2.72 Bn |
| Jun 30, 2023 | 2.63 Bn |
| Mar 31, 2023 | 2.45 Bn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 2.25 Bn |
| Jun 30, 2022 | 2.13 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 1.84 Bn |